EZH2 and cancer: EZH2 inhibitors are frequently used to prevent unwanted histone methylation of tumor suppressor genes when EZH2 is aberrantly expressed in cancer cells or mutated (gain of function, Y641 in the SET domain) [9, 77, 119].